| Year |
Citation |
Score |
| 2020 |
Mendez-David I, Guilloux J, Shah A, Tritschler L, Defaix C, Fossati P, Colle R, Hen R, Denny C, Gardier A, Corruble E, David D. Serotonin 3 Receptor Blockade is Involved in Vortioxetine -Induced Prevention of Anxiety/Depression Relapse Phenotype Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1125 |
0.743 |
|
| 2020 |
Prevot T, Li G, Knutson D, Mondal P, Mian Y, Guilloux J, Mendez-David I, David D, Cook J, Sibille E. Improved Cognitive Functions and Neurotrophic Effects of a Novel Molecule Enhancing α5-GABA-A Receptor Function in Adult or Aged Mice Biological Psychiatry. 87: S404. DOI: 10.1016/J.Biopsych.2020.02.1032 |
0.724 |
|
| 2019 |
Faye C, Hen R, Guiard B, Denny C, Gardier A, Mendez-David I, David D. Rapid anxiolytic effects of 5-HT4 receptor agonist involves prefrontal cortex-brainstem neural circuit recruitment European Neuropsychopharmacology. 29: S204-S205. DOI: 10.1016/j.euroneuro.2018.11.338 |
0.687 |
|
| 2019 |
El-Hage W, Etievant A, Belzung C, David D, Bouakaz A. Neurostimulation for depression: Evidence from preclinical models Encephale-Revue De Psychiatrie Clinique Biologique Et Therapeutique. 45. DOI: 10.1016/J.Encep.2019.04.057 |
0.426 |
|
| 2019 |
Mendez-David I, Guilloux J, Tritschler L, Defaix C, Faye C, Colle R, Corruble E, Gardier A, Fossati P, David D. S137. Long-Term Effects of Vortioxetine (Lu AA21004) on Adult Hippocampal Neurogenesis Prevents Reinstatement of Anxiety/Depression-Like Phenotype in Mice Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.888 |
0.745 |
|
| 2019 |
Guilloux J, Mendez-David I, Henry C, Attali D, Plaze M, Gardier A, Gaillard R, David D. S132. Peripheral Signature of Response to Electroconvulsive Seizure in a Murine Model of Anxiety/Depression Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.883 |
0.702 |
|
| 2018 |
Faye C, Mendez-David I, Guiard B, Denny C, Hen R, Gardier A, David D. Rapid anxiolytic effects of a serotonin type 4 receptor agonist involve prefrontal cortex/brainstem neural circuit recruitment European Neuropsychopharmacology. 28: S21-S22. DOI: 10.1016/j.euroneuro.2017.12.040 |
0.759 |
|
| 2018 |
Faye C, Hen R, Guiard B, Denny CA, Gardier A, Mendez-David I, David D. T37. Rapid Anxiolytic Effects of a Serotonin Type 4 Receptor Agonist Involve Prefrontal Cortex-Brainstem Neural Circuit Recruitment Biological Psychiatry. 83: S143. DOI: 10.1016/J.Biopsych.2018.02.373 |
0.726 |
|
| 2017 |
Taranu A, Asmar KE, Colle R, Ferreri F, Polosan M, David D, Becquemont L, Corruble E, Verstuyft C. The COMT Val(108/158)Met Genetic Polymorphism can not be Recommended as a Biomarker of Prediction of Venlafaxine Efficacy in Patients treated in Psychiatric settings. Basic & Clinical Pharmacology & Toxicology. PMID 28627776 DOI: 10.1111/Bcpt.12827 |
0.314 |
|
| 2016 |
Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology. 105: 142-53. PMID 26764241 DOI: 10.1016/J.Neuropharm.2015.12.022 |
0.732 |
|
| 2013 |
Mørk A, Pehrson A, Betry C, David D, Li Y, Gulinello M, Leiser S, Haddjeri N, Sánchez C. P.2.e.002 Vortioxetine (Lu AA21004), a multimodal antidepressant: differentiation from current antidepressants in animal models of depression European Neuropsychopharmacology. 23: S392-S393. DOI: 10.1016/S0924-977X(13)70620-5 |
0.443 |
|
| 2013 |
Dantec YL, Hache G, Quesseveur G, Guiard B, Guilloux J-, David D, Gardier A, Escourrou P. Caractérisation des altérations veille/sommeil dans un modèle murin neuroendocrinien d’anxiété/dépression Neurophysiologie Clinique-Clinical Neurophysiology. 10: 117. DOI: 10.1016/J.Neucli.2013.01.102 |
0.486 |
|
| 2010 |
Rainer Q, Gabriel C, Mocaer E, Xia L, Hen R, Enhamre E, Guilloux J, Gardier A, David D. P01-74 - Beneficial effects of chronic treatment with agomelatine on the anxiety-and depression-like state induced by corticosterone in C57BL/6NTAC mice European Psychiatry. 25: 295. DOI: 10.1016/S0924-9338(10)70293-5 |
0.741 |
|
| 2006 |
Meshi D, Drew MR, Saxe M, Ansorge MS, David D, Santarelli L, Malapani C, Moore H, Hen R. Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment. Nature Neuroscience. 9: 729-31. PMID 16648847 DOI: 10.1038/Nn1696 |
0.668 |
|
| 2003 |
Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M, Changeux JP. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. The European Journal of Neuroscience. 17: 1329-37. PMID 12713636 DOI: 10.1046/j.1460-9568.2003.02564.x |
0.536 |
|
| 2001 |
Gardier AM, Trillat AC, Malagié I, David D, Hascoët M, Colombel MC, Jolliet P, Jacquot C, Hen R, Bourin M. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ]. Comptes Rendus De L'AcadéMie Des Sciences. SéRie Iii, Sciences De La Vie. 324: 433-41. PMID 11417564 DOI: 10.1016/S0764-4469(01)01332-4 |
0.693 |
|
| 2001 |
Gardier A, Trillat A, Malagié I, David D, Hascoët M, Colombel M, Jolliet P, Jacquot C, Hen R, Bourin M. Role of 5-HT1B auto- and heteroreceptors in the mechanism of action of selective serotonin reuptake inhibitors in mice European Neuropsychopharmacology. 11: S208. DOI: 10.1016/S0924-977X(01)80182-6 |
0.483 |
|
| Show low-probability matches. |
